Rheumatoid arthritis is a chronic inflammatory disease. The generation of reactive oxygen species (ROS) within an inflamed joint has been suggested as playing a significant pathogenic role. Extracellular superoxide dismutase (EC-SOD) is a major scavenger enzyme of ROS, which has received growing attention for its therapeutic potential. To investigate the therapeutic effect of EC-SOD in mice with collagen-induced arthritis (CIA), we used mouse embryonic fibroblast (MEF) of transgenic mice that overexpresses EC-SOD on the skin by using hK14 promoter. DBA/1 mice that had been treated with bovine type II collagen were administrated subcutaneous injections of EC-SOD transgenic MEF (each at 1.4 × 10 6 cells) on days 28, 35, and 42 after primary immunization. To test EC-SOD activity, blood samples were collected in each group on day 49. The EC-SOD activity was nearly 1.5-fold higher in the transgenic MEF-treated group than in the nontransgenic MEF-treated group (p < 0.05). The severity of arthritis in mice was scored in a double-blind manner, with each paw being assigned a separate clinical score. The severity of arthritis in EC-SOD transgenic MEF-treated mice was significantly suppressed in the arthritic clinical score (p < 0.05). To investigate the alteration of cytokine levels, ELISA was used to measure blood samples. Levels of IL-1β and TNF-α were reduced in the transgenic MEF-treated group (p < 0.05). Abnormalities of the joints were examined by H&E staining. There were no signs of inflammation except for mild hyperplasia of the synovium in the transgenic MEF-treated group. The proliferation of CII-specific T cells was lower in the transgenic MEFtreated mice than in those in the other groups. The transfer of EC-SOD transgenic MEF has shown a therapeutic effect in CIA mice and this approach may be a safer and more effective form of therapy for rheumatoid arthritis.
INTRODUCTION
duce proinflammatory cytokines, including tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1), IL-6, and IL-8, which can enhance synovial inflammation (13). Rheumatoid arthritis (RA) is a severe autoimmune disease that is characterized by chronically inflamed sy-While the pathogenesis of RA remains unclear, reactive oxygen species (ROS) within the inflamed joint novium densely crowded with lymphocytes, which can result in the destruction of cartilage and bone (15, 49) .
have been indicated as being involved as inflammatory mediators in the induction of arthritis, by the augmen-The initiating event of RA is followed by the induction of an immune response that results in inflammation in tation of inflammation in RA (17) . ROS such as superoxide (O 2 − ), hydroxyl radicals (OH − ), and hydrogen per-the synovial membrane and the lining of the joint, which is usually composed of macrophage and fibroblast-like oxide (H 2 O 2 ), derived from activated macrophage and granulocytes infiltrating arthritic joints, are involved in cells known as synoviocytes (45). These cells can pro-the pathogenesis of RA. A high level of ROS can lead sected on day 13.5 of pregnancy, and the embryos were collected. The embryos were placed in phosphate-to direct damage to hyaluronic acid (31) , lipids (46) , cartilage matrix (3) , and DNA (18). ROS may also contrib-buffered saline (PBS), and the internal organs and heads of these embryos were removed. The remaining torsos ute to disease through the induction of proinflammatory cytokines. After a period of hypoxia, reoxygenated hu-were minced and placed into 0.25% trypsin/0.02% EDTA for 30 min at 30°C. The torsos were suspended man monocytes produce large amounts of IL-1 stimulated by ROS (22) . Also, TNF-α is produced by alveolar by pipetting, and the reaction was stopped with an incubation medium (Dulbecco's modified Eagle's medium macrophages (42) and monocytes (47) after stimulation with ROS.
with 10% FBS, 0.06 mg/ml of penicillin G, 0.06 mg/ ml streptomycin, and 2.5 mM sodium pyruvate). The Superoxide dismutases (SODs) are the key antioxidant enzymes in the metabolism of ROS. These enzymes adherent cells were collected and cultured. The media were replaced every 3 days, and all spindle-shaped cells catalyze the following reaction: (8, 14) . Three different isoforms of SOD exist in were used as embryonic fibroblasts. mammals (28) . A copper-and zinc-containing form of RT-PCR superoxide dismutase (Cu/Zn-SOD or SOD-1) is widely distributed in the cytosol and nucleus, but it is notice-Total RNA was isolated from the transgenic and nontransgenic MEF using TRIzol reagents (M.R.C, USA) ably absent from mitochondria and secretory compartments (9). Second, manganese SOD (Mn-SOD or SOD-according to the manufacturer's protocol. To exam the expression of cytokines, spleens were also isolated from 2) is a manganese-containing enzyme that is localized in the mitochondrial matrix. Finally, extracellular SOD each group on day 49. Total RNA (1 µg) was reversetranscribed using a first-strand cDNA synthesis kit (Pro-(EC-SOD or SOD-3) is the most recently discovered SOD family member (4) . Unlike Cu/Zn-SOD and Mn-mega, USA). Synthesized cDNA was amplified with the following primers: EC-SOD forward 5′-CGG TTG SOD, EC-SOD is found in the extracellular matrix of tissue and extracellular fluids, such as serum, cerebro-AGA TAG ACA GG-3′ and reverse 5′-TTA AGT GGT CTT GCA CTC G-3′; IL-1β forward 5′-CTA AAG spinal, ascites, and synovial fluids (29, 35) .
Recently, decreased serum levels of IL-1β and TNF-TAT GGG CTG GAC TG-3′ and reverse 5′-AGC TTC AAT GAA AGA CCT CA-3′; TNF-α forward 5′-TGT α were observed after treating collagen-induced arthritis (CIA) by a gene transfer of EC-SOD (19) , and EC-SOD-CTA CTG AAC TTC GGG GT-3′ and reverse 5′-TCA CAG AGC AAT GAC TCC AA-3′; TGF-β forward 5′-deficient mice showed marked increases in mRNA levels of these cytokines in the joints (38) . The results of ACC GCA ACA ACG CCA TCT AT-3′ and reverse 5′-GTA ACG CCA GGA ATT GTT GA-3′. PCR was car-the studies of EC-SOD-deficient mice indicate an important role for endogenous EC-SOD in protecting against ried out in a Takara Thermal. A quantitative assay was normalized to GAPDH. joint inflammation and destruction in CIA. In addition, EC-SOD has been revealed as playing a protective role Induction of Collagen-Induced Arthritis (CIA) in inflammatory responses (26) . CIA in rats is inhibited by the administration of an SOD mimetic (39) and it is Six-week-old male DBA/1 mice were purchased from Charles River (Yokohama, Japan). Bovine type II colla-ameliorated by the ex vivo gene transfer of EC-SOD into the knee joints (10). The present study investigated gen (CII, Chondrex, USA) was dissolved as 0.25% in 0.01 N-acetic acids. Mice were immunized on day 0 the efficacy of EC-SOD in CIA mice, using EC-SOD transgenic mouse embryonic fibroblasts (MEF).
with an intradermal injection of 100 µg CII, emulsified in complete Freund's adjuvant (CFA). On day 14, the MATERIALS AND METHODS mice were boosted into the left footpad with the same Preparation of EC-SOD Mouse Embryonic amount of CII in an incomplete Freund's adjuvant Fibroblast (MEF) (IFA). Three weeks after primary immunization, the clinical scores of the mice were examined two to three EC-SOD transgenic mouse models have been generated in our previous study (21) . In order to induce the times a week for the onset and severity of arthritis. The severity of arthritis was scored in a double-blind man-skin-specific expression of mouse EC-SOD, the human keratin 14 (hK14) promoter, which has been described ner, with each paw assigned a separate clinical score (32) as follows: 0 = normal; 1 = erythema and mild swelling as a keratinocyte-specific promoter (20, 44) , was cloned. EC-SOD transgenic mouse lines were established by confined to the ankle joint and toes; 2 = erythema and mild swelling extending from the ankle to the midfoot; breeding them into C57BL/6 × C3H hybrid mice. To produce EC-SOD transgenic MEF, transgenic mice were 3 = erythema and severe swelling extending from the ankle to the metatarsal joints; and 4 = ankylosing defor-backcrossed with wild-type DBA/1 mice through at least six generations. Pregnant mice were sacrificed and dis-mity with joint swelling.
EC-SOD MEF Cell
Grafting stained with hematoxylin and eosin (H&E). The fixed and stained slides of the joint sections were read by a After immunization with CII, mice were randomly trained observer. separated into three different groups. The mice of the first group were injected subcutaneously with EC-SOD Statistical Analysis MEF (each at 1.4 × 10 6 cells) at four sites on the back Data were analyzed by chi-square analysis to deterthree times on days 28, 35, and 42 after the first immunimine differences between groups. A value of p < 0.05 zation. The second group was administered the same was considered to be statistically significant. amount of nontransgenic MEF three times on the same days. The third CII-immunized group was left untreated RESULTS as a disease control group.
Identification of EC-SOD MEF Measurement of EC-SOD Activity in Sera
The level of mouse EC-SOD mRNA in the transgenic MEF was examined using the RT-PCR method. The set To test EC-SOD activity, blood samples were colof primers used in this study was specific to the mouse lected in each group on day 49 using the eye-bleeding EC-SOD. Figure 1 shows the expression of the EC-SOD method. Collected sera were stored at −76°C until use.
in transgenic MEF and nontransgenic MEF. The expres-To measure EC-SOD activity in sera, a SOD assay kitsion levels of mouse EC-SOD in the EC-SOD transgenic WSP (Dojindo Molecular Technologies, MD, USA) was MEF were highly expressed compared to the nontransused.
genic MEF.
Cytokine Assay in Sera
Clinical Evaluation of Arthritis We also measure TNF-α and TGF-β levels using
The therapeutic effect of EC-SOD transgenic MEF commercially available ELISA kits (Quantikine Mouse grafting was examined using a mouse CIA model. Mice IL-1β, TNF-α, and TGF-β immunoassay, R&D Sysimmunized with CII received an injection of EC-SOD tems, Minneapolis, MN, USA). Optical absorbance was transgenic MEF. The cells were injected three times, on measured using an ELISA reader at 450 nm. days 28, 35, and 42 postimmunization, into the subcuta-Assessment of T-Cell Proliferation neous tissue of the back. The control mice were injected Inguinal and popliteal lymph nodes (LN) and the with EC-SOD nontransgenic MEF or were left unspleen were removed from each group of mice 60 days treated. Clinical scores were monitored after the first imafter the primary immunization, and washed in RPMImunization. All animals developed some detectable 1640. Tissue samples were pooled from four or five level of disease activity. In the EC-SOD transgenic mice, minced into single-cell suspensions in RPMI-MEF-treated group, however, the clinical score curve 1640, and washed three times with RPMI-1640. Cells was significantly suppressed (p < 0.05) compared to the (5 × 10 5 /well) were cultured in 96-well microtiter plates CIA and nontransgenic MEF-treated groups, until day (Nunc, Rosklide, Denmark) with or without 40 µg/well 49 ( Fig. 2) . Thereafter, the curve tended to rise again. CII in 0.3 ml Click's medium (Irvine Scientific, CA,
The data indicate that the transfer of EC-SOD transgenic USA), supplemented with 0.5% mouse serum, at 37°C MEF significantly reduced the severity of inflammation, in 5% humidified CO 2 for 4 days. To assess the rate of which is compatible with the clinical scores (p < 0.05). proliferation, 1 µCi of [ 3 H]thymidine was added to each EC-SOD Activity in Sera well, and the cells were harvested 18 h later on to glass fiber filters and counted on a matrix 96 direct ionization
The level of EC-SOD in sera from each group was tested on day 49. Figure 3 shows EC-SOD activities in beta counter (Packard Instrument, USA). The data are presented as stimulation indexes, which were calculated the transgenic MEF-treated group and the nontransgenic MEF-treated group. As shown in Figure 3 , the EC-SOD as the ratio of cpm in the presence of CII, divided by cpm without CII.
activity was nearly 1.5-fold higher in the transgenic MEF-treated group than in the nontransgenic MEF-Histological Analysis treated group (p < 0.05). This means that the transgenic For a histological examination of the joints, mice MEF injected into these mice survived and produced were killed on day 60. The right hind limb of all animals EC-SOD during the arthritis progress. was surgically removed, the muscle and skin were Cytokine Assay by RT-PCR and ELISA trimmed off, and tissue samples were fixed in 10% buffered formalin. The limbs were decalcified in a histolog-
The expression patterns of the cytokines in the spleens from each group of mice were tested by RT-ical decalcifying agent (Calci-Clear Rapid, National Diagnostics, USA), embedded in paraffin, sectioned, and PCR (Fig. 4) . IL-1β and TNF-α were more highly ex- pressed in the CIA group more than in the other groups. T-Cell Proliferation To confirm these results, the cytokine level in mice sera was also determined using ELISA (Fig. 5 
). As shown in
We looked for changes in the proliferative response of the CII-specific lymph node and spleen cells in CII- Figure 5 , levels of both IL-1β and TNF-α of the EC-SOD transgenic MEF-treated and nontransgenic MEF-immunized mice (Fig. 6 ). Sixty days after the primary CII injection, the lymph node and spleen cells were har-treated group were significantly elevated in comparison with the CIA groups (p < 0.05) (Fig. 5A, B) . The levels vested. T-cell proliferation assay was performed by [ 3 H]thymidine analysis, as described in Materials and of TGF-β in the transgenic MEF-treated group were not significantly different among the groups (Fig. 5C ).
Methods. The proliferation of T cells was increased 1.5-2-fold after the administration of CII in all groups.
Histological Analysis In the lymph node cell, the proliferation of T cells in the transgenic or nontransgenic MEF-treated group was
The effect of EC-SOD transgenic MEF on joint histological features in CIA mice was examined by H&E significantly suppressed compared to the CIA group but not in spleen cells (p < 0.05) (Fig. 6) . These results indi-staining. As shown in Figure 7 , there were some typical histological features in the joint cavity of CIA mice, cate that EC-SOD suppressed the proliferation of T cells in the transgenic MEF-treated group.
nontransgenic MEF-treated CIA mice, and CIA mice re- ceiving three injections of EC-SOD transgenic MEF. In phils, and chondrocytes (23) to generate superoxide, which in turn activates osteoclasts (16), thus resulting in the CIA and nontransgenic MEF-treated CIA mice, the destruction of cartilage and bone, the infiltration of mo-bone resorption. Furthermore, TNF-α stimulates synovial cells to undergo proliferation (34) . IL-1β also stim-nonuclear cells, and the proliferation of synovial cells were observed, while in the CIA mice that had been ulates chondrocytes and synovial cells to generate superoxide, which in turn activates metalloproteinase, treated with EC-SOD transgenic MEF, there were no signs of inflammation except for mild hyperplasia of the resulting in cartilage matrix degeneration (41) . In this study, we examined the levels of TNF-α and IL-1β in synovium.
the circulation and found a substantial reduction of these DISCUSSION cytokines in the CIA mice treated with the EC-SOD MEF, compared with nontreated CIA mice. This result The current study demonstrates the therapeutic effects of the transfer of EC-SOD MEF to the autoimmune indicates that the chosen approach efficiently suppressed the production of proinflammatory cytokines. The trans-disease mouse model. The transfer of EC-SOD MEF to CIA mice was initiated at day 28 after primary immuni-fer of EC-SOD MEF to CIA mice also reduced the proliferation of CII-specific T cells. We confirmed reduc-zation, as defined by clinical scores and swollen hind paws. The transfer of EC-SOD MEF to CIA mice has tion of the T-cell proliferation of CII-specific T cells in lymph node cells and this maybe contributes to the effi-shown a therapeutic effect on the arthritic score and histological analysis of joints. This was considered as the cacy of our treatment strategy, given that CIA is closely dependent on T cells (7,12). Unexpectedly, a reduction result of the suppression of inflammatory cytokines and the CII-specific T-cell proliferation by EC-SOD.
in TNF-α and IL-1β levels, and in the CII-specific Tcell proliferation in the nontransgenic MEF-treated The pathogenic role of inflammatory cytokines, including TNF-α and IL-1β, is crucial to the progression group was found. As shown in Figures 1 and 3 , nontransgenic MEF also expressed EC-SOD. Although of arthritis. TNF-α stimulates macrophages (48), neutro- Figure 7 . A histological analysis of the joints of mice with CIA. All mice were sacrificed on day 60 and the right hind limbs were taken for histology and stained with H&E. The joints of transgenic MEF-treated mice (A), nontransgenic MEF-treated mice (B), and CIA mice (C) are shown. In EC-SOD transgenic MEF-treated CIA mice, there were no signs of inflammation except mild hyperplasia of synovium (20× magnification; arrows show histological abnormalities). these were expressed less in nontransgenic MEF less Although the introduction of viral particles into the joint can be avoided, the methylation of the cytomegalovirus than in EC-SOD MEF, it seemed that endogenous EC-SOD from the nontransgenic MEF might affect the level (CMV) promoter of the retroviral vector shuts off the transgene (5). Using Chinese hamster ovaries (CHO) fi-of these cytokines and the T-cell proliferation response.
Other research has already shown that the administra-broblast transduced the IL-4 gene with plasmid as nonviral vector cell therapy, and xenogenic vector cells tion of EC-SOD is efficient in CIA animal models. In previous studies, viral vectors, such as adenovirus (30) were rejected after a few days (1) . Mouse EC-SOD was administered using transgenic and retrovirus (37) , have been widely applied as gene therapy in experimental RA models. These viral vectors mouse embryonic fibroblast cell. With this approach, no viral particles were introduced into the joint, which provide a transient high-level expression of transgene. Considering the safety of viral vectors, there are potent means that there can be no sensitization of the animal model to viral proteins. The subcutaneous injection of risks to patients, including death, who have been administrated an adenoviral vector (30) combined with having transgenic MEF from which EC-SOD may be released systemically into the circulation, as opposed to local in-developed severe leukemia, along with immune-deficient patients who have received retroviral transduced jection of the gene into the joints, provides a better means for treating arthritis affecting multiple joints, as hematopoietic stem cells (37) . To overcome these problems, the ex vivo method, using a retroviral transduced in RA. Furthermore, the mouse EC-SOD overexpression model was used, which was back-crossed with normal MEF with EC-SOD gene, has been applied to CIA (19) . sensitive to hyperoxia. Proc. Natl. Acad. Sci. USA 92: DBA/1 mice over at least six generations. The MEF of 6264-6268; 1995. these transgenic mice had almost the same genetic back-5. Challita, P. M.; Kohn, D. B. Lack of expression from a ground as DBA/1, which would prevent immune rejecretroviral vector after transduction of murine hematopoition. Thus, we thought that the chosen approach in using etic stem cells is associated with methylation in vivo. Proc. Natl. Acad. Sci. USA 91:2567-2571; 1994. transgenic MEF would deliver EC-SOD to patients more 6. Chang, L. Y.; Crapo, J. D. Inhibition of airway inflammasafely than previous approaches. We also identified that the arthritis level of CIA mice. This effect in the joints Collagen-induced arthritis development requires alpha beta T cells but not gamma delta T cells: studies with T-was verified by histological analysis (Fig. 7) . We expect cell-deficient (TCR mutant) mice. Int. Immunol. 11:1065our approach will be able to be applied to other disease 1073; 1999. models. Several studies have also shown the efficacy of 
